CN Patent

CN116672309A — 干混悬药物组合物

Assigned to Beijing Punuo Wang Kang Pharmaceutical Technology Co ltd · Expires 2023-09-01 · 3y expired

What this patent protects

本发明公开了一种干混悬药物组合物。由如下重量百分比的组分构成：利那洛肽0.005‑0.02%、磷霉素氨丁三醇30‑60%、填充剂30‑60%、助悬剂0.5‑2.0%、崩解剂0.5‑3.0%、稳定剂0.3‑1.5%、矫味剂0.02‑2.0%、着色剂0.5‑3.0%、pH调节剂0.1‑3.0%。本发明制备的干混悬组合物比单方制剂具有更好的发挥治疗便秘的效果，发明人所研制的干混悬组合物填补了市场空白，给患者提供了新的治疗选择，且方便了患者用药，提高患者用药的顺从性。

USPTO Abstract

本发明公开了一种干混悬药物组合物。由如下重量百分比的组分构成：利那洛肽0.005‑0.02%、磷霉素氨丁三醇30‑60%、填充剂30‑60%、助悬剂0.5‑2.0%、崩解剂0.5‑3.0%、稳定剂0.3‑1.5%、矫味剂0.02‑2.0%、着色剂0.5‑3.0%、pH调节剂0.1‑3.0%。本发明制备的干混悬组合物比单方制剂具有更好的发挥治疗便秘的效果，发明人所研制的干混悬组合物填补了市场空白，给患者提供了新的治疗选择，且方便了患者用药，提高患者用药的顺从性。

Drugs covered by this patent

Patent Metadata

Patent number
CN116672309A
Jurisdiction
CN
Classification
—
Expires
2023-09-01
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Punuo Wang Kang Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.